Japanese Clinical Practice Guideline for Diabetes 2016.
Japanese Clinical Practice Guideline for Diabetes 2016.
复制标题
DOI：
10.1111/jdi.12810
复制
发表时间：
2018-03-26
影响因子：
3.2
通讯作者：
Araki E
中科院分区：
文献类型：
--
作者：
Haneda M;Noda M;Origasa H;Noto H;Yabe D;Fujita Y;Goto A;Kondo T;Araki E
Since its inception in 2004, the “Clinical Practice Guidelines for the Treatment of Diabetes” has attempted to promote evidence-based, rational, efficient and standardized clinical practice for diabetes in Japan and has undergone revisions every 3 years. Thus, the current edition represents the fifth revision.Of note, in recent years, breakthroughs have been made in the management of diabetes and its complications, which include the approval of glucose-lowering agents with novel mechanisms of action for clinical use and the introduction and adoption of novel diagnostic and therapeutic modalities, such as continuous glucose monitoring (CGM) and sensoraugmented insulin pumps (SAP), in clinical practice. Again,
登录
查看更多内容
影响因子：
16.2
作者：
通讯作者：
--
影响因子：
105.7
作者：
Adler, AI;Stratton, IM;Holman, RR
通讯作者：
Holman, RR
影响因子：
16.2
作者：
通讯作者：
--
影响因子：
13.6
作者：
Afkarian, Maryam;Sachs, Michael C.;de Boer, Ian H.
通讯作者：
de Boer, Ian H.